EUVIMEDEUVIMED entdecken
Open Access

Testican-2 Interaction with the Extracellular Matrix and Podocyte Protection

Donghai Wen, Qian Zhang iD, Johannes van Agthoven iD, Astrid Weins iD, Ivy A Rosales iD, Wen Zhou iD, Taesoo Kim iD, Xavier Vela Parada, Robert B Colvin iD, Martin R Pollak iD, Morgan E Grams iD, Insa M Schmidt iD und 3 weitere

Journal of the American Society of Nephrology · 2026

DOI: 10.1681/asn.0000000915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026. Verfasst von Donghai Wen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Division, Mass General Brigham, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Podocytes, Extracellular Matrix, Extracellular Matrix Proteins, Glycoproteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Testican-2 reduced adriamycin-induced podocyte injury in vitro and in vivo . Testican-2 interacted with vitronectin and reduced vitronectin-mediated integrin α V β 3 activation in vitro . Exogenous testican-2 circulated to the kidney, bound vitronectin, and conferred podocyte protection, even when endogenous testican-2 was absent.

Background

Testican-2 is a podocyte-derived glycoprotein encoded by SPOCK2 . Circulating levels of testican-2 are associated with less glomerulosclerosis and better kidney prognosis, but its biologic function in the podocyte is unknown.

Methods

We studied the protective effect of testican-2 on immortalized cultured human podocytes and in mice treated with adriamycin. We used immunoprecipitation mass spectrometry to identify binding partners of testican-2 and biolayer interferometry to characterize these protein–protein interactions. Using global and podocyte-specific Spock2 knockout mice, we assessed the effect of testican-2 deficiency in models of podocyte injury and also tested whether exogenous testican-2 confers podocyte protection in testican-2–deficient mice. Finally, we analyzed testican-2 expression in human kidney biopsy samples.

Results

Testican-2 reduced adriamycin-induced podocyte injury in cultured human podocytes and mice. Vitronectin was a strong binding partner for testican-2, and testican-2 inhibited the interaction between vitronectin and integrin α V β 3, an effector of podocyte injury. Consistent with this, testican-2 administration reduced activation of integrin β 3 in injured podocytes. Furthermore, Spock2 deficiency increased susceptibility to podocyte injury due to adriamycin- and streptozotocin-induced diabetes, as determined by albuminuria, foot process effacement, nephrin expression, and Wilms' tumor 1-positive podocyte number. Importantly, exogenous testican-2 circulated to the kidney, bound to vitronectin, reduced vitronectin-integrin β 3 interaction, and reduced podocyte injury in Spock2 -deficient mice. Finally, glomerular testican-2 expression was reduced in human focal segmental glomerulosclerosis and diabetic kidney disease, but not tubulointerstitial nephropathy.

Conclusions

Testican-2 modulated the podocyte's interaction with its extracellular matrix and had a functional role in kidney protection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesExtracellular MatrixExtracellular Matrix ProteinsGlycoproteinsAnimalsHumansDoxorubicinMiceVitronectinMice, KnockoutIntegrin alphaVbeta3MaleCells, Cultured

Stichwörter der Autor:innen

biomarkerscell-matrix interactionsextracellular matrixpodocyte

Substanzen

DoxorubicinVitronectinIntegrin alphaVbeta3Extracellular Matrix ProteinsGlycoproteins

Autor:innen und Institutionen

  • Nephrology Division, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.
  • Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.
  • Division of Nephrology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts.
  • Division of Nephrology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

ORCID-Profile: Qian Zhang, Johannes van Agthoven, Astrid Weins, Ivy A Rosales, Wen Zhou, Taesoo Kim, Robert B Colvin, Martin R Pollak, Morgan E Grams, Insa M Schmidt, M Amin Arnaout, Eugene P Rhee

Förderung

  • NIDDK NIH HHS
  • NIAMS NIH HHS
  • NHLBI NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Wen, D., Zhang, Q., van Agthoven, J., Weins, A., Rosales, I. A., Zhou, W., Kim, T., Vela Parada, X., Colvin, R. B., Pollak, M. R., Grams, M. E., Schmidt, I. M., Waikar, S. S., Arnaout, M. A., & Rhee, E. P. (2026). Testican-2 Interaction with the Extracellular Matrix and Podocyte Protection. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000000915

Vancouver

Wen D, Zhang Q, van Agthoven J, Weins A, Rosales IA, Zhou W, et al. Testican-2 Interaction with the Extracellular Matrix and Podocyte Protection. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000000915

BibTeX
@article{Wen2026,
  author = {Wen, Donghai and Zhang, Qian and van Agthoven, Johannes and Weins, Astrid and Rosales, Ivy A and Zhou, Wen and Kim, Taesoo and Vela Parada, Xavier and Colvin, Robert B and Pollak, Martin R and Grams, Morgan E and Schmidt, Insa M and Waikar, Sushrut S and Arnaout, M Amin and Rhee, Eugene P},
  title = {Testican-2 Interaction with the Extracellular Matrix and Podocyte Protection},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.1681/asn.0000000915}
}
Kostenlos starten →